Nutraveris
Tuesday, July 2, 2019
Category : NEWS, REGULATORY | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

EFSA published on 15 May 2019 a technical report on Risk evaluation of chemical contaminants in food in the context of RASFF notifications.

EFSA technical report on Risk evaluation of chemical contaminants in food in the context of RASFF notifications

 

An evaluation on the level of risk is necessary to decide if a RASFF notification should be issued. EFSA was requested to propose a risk evaluation methodology that would allow a rapid and consistent risk‐based classification of RASFF notifications.

The methodology aims to provide a transparent set of criteria that can support the decision whether to notify in RASFF and increase transparency and harmonization. The methodology was developed for evaluation of contaminants (arising from food contact materials, pharmacologically active substances and other food contaminants) in food.

The risk evaluation is based on the assessment of toxicological properties and dietary exposure. The result, expressed as the comparison of exposure to a relevant toxicological reference point, can be classified as no risk; low probability of adverse health effects or low concern for public health; potential risk; or risk.

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, June 25, 2019
Category : NEWS, INGREDIENTS, INNOVATION, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

In collaboration with Amway (USA), Nutraveris, the leading European consultancy in nutrition and health, has obtain two news novel food approvals by EFSA. These applications were related to two specific chia seeds extracts (Salvia hispanica L.), on Chia seed fiber and one Chia seed protein preparation, for use in food supplements and in a range of foodstuffs. The target population was adults from the general population, excluding children, pregnant and breastfeeding women.

Nutraveris: two news novel food approvals by EFSA

 

Submitted as soon as the new novel food regulation was in place, both applications have been evaluated simultaneously.

EFSA recognized that both Chia seed extracts are safe for the use of food supplements intended for the general population, and in several food categories such as milk products, confectionery or fruit juices and other beverages.

These successes demonstrate once again the strengths of Nutraveris, either in the preparation and submission of Novel Food applications, and in its follow-up during EFSA evaluation. Do not hesitate to contact our team to obtain authorization for your ingredients.

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, June 6, 2019
Category : NEWS, INGREDIENTS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

This randomized, double-blind, placebo-controlled study was conducted to assess the efficacy of supplementation during 84 days, with an Andrographis paniculata extract (300 or 600 mg/d), on osteoarthritis pain in 103 patients with knee osteoarthritis.

Effects of an Andrographis paniculata extract on pain reduction in subjects with knee osteoarthritis.

Patients supplemented with 300 or 600 mg/day of the extract showed a significant reduction in pain at days 28, 56, and 84 compared with a placebo group. WOMAC stiffness scores, physical function score, and the fatigue score showed a significant improvement with both doses of supplement compared with the placebo group. At the end of the study, the quality of life and functional assessment of chronic illness therapy scores showed significant improvements with both doses compared with the placebo group.

 

In conclusion, Andrographis paniculata extract in 300 and 600 mg/day dosages were found to be effective in reducing pain in individuals suffering from mild to moderate knee osteoarthritis.

 

Hancke JL, Srivastav S, Cáceres DD, Burgos RA. A double-blind, randomized, placebo-controlled study to assess the efficacy of Andrographis paniculata standardized extract (ParActin®) on pain reduction in subjects with knee osteoarthritis. Phytother Res. 2019 Apr 10.

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, June 4, 2019
Category : NEWS, REGULATORY | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

 vitamin D and erucic acid

The Delegated Regulation (EU) 2019/828 published on 23 May 2019 amends the Delegated Regulation (EU) 2016/127 with regard to vitamin D requirements for infant formula and erucic acid requirements for infant formula and follow-on formula:

The maximum content for vitamin D in infant formula is lowered to 2,5 μg/100 kcal (instead of 3 μg/100 kcal).

the maximum content for erucic acid in infant formula and follow-on formula is lowered to 0,4 % of the total fat content (instead of 1%).

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, May 30, 2019
Category : NEWS, INGREDIENTS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

Our Artificial Intelligence solutions, developed by our experts, NOL Datasolution to Create & NOL Compliance to Launch your products, inform you :  

 

This double-blind, randomized, placebo-controlled study, evaluated among 92 patients with non-alcoholic fatty liver disease (NAFLD) the effects of supplementation with either 3 g/d of turmeric or 9 g/d of infused chicory seed (4.5 g /100mL) or both turmeric and chicory seed or a placebo during 12 weeks.

Beneficial effects of chicory seedsTurmeric supplementation on the lipid profile and obesity markers

At the end of the supplementation period, results showed a significant decrease in body mass index and waist circumference in chicory and mixture groups (p < 0.05 vs. placebo). Combination of turmeric and chicory seed significantly decreased serum alkaline phosphatase level (p < 0.05). Serum levels of HDL-Cholesterol increased considerably in turmeric and mixture groups (p < 0.05 vs. placebo). Moreover, turmeric and mixture supplementations led to significant reduction in serum levels of triglycerides/HDL-Cholesterol and LDL-Cholesterol/HDL-Cholesterol ratio (p < 0.05 vs. placebo).

In conclusion, turmeric and chicory seed supplementation can be significantly useful in management of NAFLD risk factors.

 

Ghaffari A, Rafraf M, Navekar R, Sepehri B, Asghari-Jafarabadi M, Ghavami SM. Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD). Int J Vitam Nutr Res. 2019 Apr 24:1-10.

 

NUTRAVERIS is the Leading European consultancy on Regulatory & Scientific affairs in Nutrition and Health, founded 13 years ago, to help you formulate, ensure the compliance and substantiation of your products in the 28 EU Member States. 

Thanks to our strong know-how and experience of regulatory compliance, notifications, novel foods, health claims, medical writing,…We, as experts, created Artificial Intelligence solutions, that we use in our everyday missions:
-NOL Datasolution to CREATE new products thanks to Regulatory, Scientific & Marketing data.
-NOL Compliance to LAUNCH products into the different EU member states thanks to automated Compliance analysis, Labeling generation and Monitoring & updating at anytime.

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87